BACKGROUND: Human obesity is characterized by high levels of leptin, and leptin levels may change with weight loss and dietary restriction. The aim of our study was to investigate the influence of Lys656Asn polymorphism in the leptin receptor gene on cardiovascular risk factors, weight loss, and serum leptin levels to a high polyunsaturated fatty acid (PUFA) hypocaloric diet in obese patients. DESIGN: A sample of 132 obese patients was analyzed in a prospective way with a dietary intervention. The enriched PUFAs hypocaloric intervention consisted in a diet of 1,459 kcal, 45.7% of carbohydrates, 34.4% of lipids, and 19.9% of proteins. RESULTS: In wild-type group, BMI (-1.9 ± 1.4 kg/m(2) ), weight (-4.4 ± 3.2 kg), fat mass (-4.2 ± 3.8 kg), waist circumference (-4.1 ± 3.1 cm), systolic blood pressure (-7.0 ± 12.1 mmHg), diastolic blood pressure (-3.9 ± 6.8 mmHg), insulin (-1.8 ± 5.6 MUI/l) and HOMA-IR (-0.5 ± 1.5 Units) decreased. In mutant genotype group, BMI (-2.0 ± 2.1 kg/m(2) ), weight (-3.6 ± 4.1 kg), waist circumference (-3.1 ± 4.1 cm), total cholesterol (-25.2 ± 19.6 mg/dl), LDL cholesterol (-16.6 ± 25.6 mg/dl), and tryglicerides (-26.6 ± 39.1 mg/dl) decreased. Only leptin levels have a significant decrease in wild genotype group (-6.6 ± 10.2 ng/ml) (25.1%). CONCLUSION: Carriers of ASn656 allele have a different response than wild-type obese, with a lack of decrease in insulin levels, leptin levels, and HOMA-IR. However, obese patients with this mutant allele have a better lipid profile after weight loss.
BACKGROUND:Humanobesity is characterized by high levels of leptin, and leptin levels may change with weight loss and dietary restriction. The aim of our study was to investigate the influence of Lys656Asn polymorphism in the leptin receptor gene on cardiovascular risk factors, weight loss, and serum leptin levels to a high polyunsaturated fatty acid (PUFA) hypocaloric diet in obesepatients. DESIGN: A sample of 132 obesepatients was analyzed in a prospective way with a dietary intervention. The enriched PUFAs hypocaloric intervention consisted in a diet of 1,459 kcal, 45.7% of carbohydrates, 34.4% of lipids, and 19.9% of proteins. RESULTS: In wild-type group, BMI (-1.9 ± 1.4 kg/m(2) ), weight (-4.4 ± 3.2 kg), fat mass (-4.2 ± 3.8 kg), waist circumference (-4.1 ± 3.1 cm), systolic blood pressure (-7.0 ± 12.1 mmHg), diastolic blood pressure (-3.9 ± 6.8 mmHg), insulin (-1.8 ± 5.6 MUI/l) and HOMA-IR (-0.5 ± 1.5 Units) decreased. In mutant genotype group, BMI (-2.0 ± 2.1 kg/m(2) ), weight (-3.6 ± 4.1 kg), waist circumference (-3.1 ± 4.1 cm), total cholesterol (-25.2 ± 19.6 mg/dl), LDL cholesterol (-16.6 ± 25.6 mg/dl), and tryglicerides (-26.6 ± 39.1 mg/dl) decreased. Only leptin levels have a significant decrease in wild genotype group (-6.6 ± 10.2 ng/ml) (25.1%). CONCLUSION: Carriers of ASn656 allele have a different response than wild-type obese, with a lack of decrease in insulin levels, leptin levels, and HOMA-IR. However, obesepatients with this mutant allele have a better lipid profile after weight loss.
Authors: Daniel Antonio de Luis; Rocio Aller; Manuel González Sagrado; Olatz Izaola; Maria Concepcion Terroba; Luis Cuellar; Rosa Conde; Tomas Martin Journal: J Gastrointest Surg Date: 2010-03-06 Impact factor: 3.452
Authors: Catherine M Phillips; Louisa Goumidi; Sandrine Bertrais; Martyn R Field; Jose M Ordovas; L Adrienne Cupples; Catherine Defoort; Julie A Lovegrove; Christian A Drevon; Ellen E Blaak; Michael J Gibney; Beata Kiec-Wilk; Britta Karlstrom; Jose Lopez-Miranda; Ross McManus; Serge Hercberg; Denis Lairon; Richard Planells; Helen M Roche Journal: J Nutr Date: 2009-12-23 Impact factor: 4.798
Authors: J E Reseland; F Haugen; K Hollung; K Solvoll; B Halvorsen; I R Brude; M S Nenseter; E N Christiansen; C A Drevon Journal: J Lipid Res Date: 2001-05 Impact factor: 5.922
Authors: M Heo; R L Leibel; B B Boyer; W K Chung; M Koulu; M K Karvonen; U Pesonen; A Rissanen; M Laakso; M I Uusitupa; Y Chagnon; C Bouchard; P A Donohoue; T L Burns; A R Shuldiner; K Silver; R E Andersen; O Pedersen; S Echwald; T I Sørensen; P Behn; M A Permutt; K B Jacobs; R C Elston; D J Hoffman; D B Allison Journal: Genetics Date: 2001-11 Impact factor: 4.562
Authors: Timo A Lakka; Tuomo Rankinen; S John Weisnagel; Yvon C Chagnon; Hanna-Maaria Lakka; Olavi Ukkola; Normand Boulé; Treva Rice; Arthur S Leon; James S Skinner; Jack H Wilmore; D C Rao; Richard Bergman; Claude Bouchard Journal: Diabetes Date: 2004-06 Impact factor: 9.461
Authors: Kerstin Kempf; Martin Röhling; Winfried Banzer; Klaus Michael Braumann; Martin Halle; Nina Schaller; David McCarthy; Hans Georg Predel; Isabelle Schenkenberger; Susanne Tan; Hermann Toplak; Stephan Martin; Aloys Berg Journal: Nutrients Date: 2022-06-18 Impact factor: 6.706